Clinical Trial Update: To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Perrigo's drug to an FDA-approved therapy for actinic keratosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• FDA-approved comparator drug
• Perrigo's drug

Snippet

Sponsor: Padagis LLC | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2021-01-22